Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inducing Immune Quiescence in the Female Genital Tract
NCT02079077Completed
- Sponsor
- University of Manitoba
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in human immunodeficiency virus infection (HIV) comparing Acetylsalicylic Acid with Hydroxychloroquine (2 arms). Primary endpoint: Changes in Systemic Immune Activation From Baseline Observed by the CD69 Expression on CD4 T Cells at 8 weeks. Started Apr 2014; status: completed.
02
Drugs
aspirinhydroxychloroquine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02079077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079077.